ARTBIO

About:

ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.

Website: https://artbio.com

Twitter/X: artbio_inc

Top Investors: F-Prime Capital, Third Rock Ventures, Omega Funds

Description:

ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines. ARTBIO is changing cancer care by creating a new class of alpha radioligand therapeutics (ART) and the ecosystem that supports.

Total Funding Amount:

$113M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)artbio.com

Founders:

Emanuele Ostuni, Roy H. Larsen, Øyvind Sverre Bruland

Number of Employees:

11-50

Last Funding Date:

2023-12-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai